Empowered Funds LLC Purchases Shares of 225,089 ASP Isotopes Inc. $ASPI

Empowered Funds LLC purchased a new stake in ASP Isotopes Inc. (NASDAQ:ASPI) during the second quarter, HoldingsChannel.com reports. The firm purchased 225,089 shares of the company’s stock, valued at approximately $1,400,000.

Several other institutional investors also recently made changes to their positions in the stock. Mercer Global Advisors Inc. ADV increased its holdings in ASP Isotopes by 8.3% in the 3rd quarter. Mercer Global Advisors Inc. ADV now owns 21,056 shares of the company’s stock valued at $203,000 after purchasing an additional 1,622 shares in the last quarter. The Manufacturers Life Insurance Company lifted its position in ASP Isotopes by 9.9% during the 2nd quarter. The Manufacturers Life Insurance Company now owns 20,840 shares of the company’s stock worth $153,000 after acquiring an additional 1,878 shares in the last quarter. Legal & General Group Plc lifted its position in ASP Isotopes by 30.4% during the 3rd quarter. Legal & General Group Plc now owns 8,377 shares of the company’s stock worth $81,000 after acquiring an additional 1,953 shares in the last quarter. The Manufacturers Life Insurance Company boosted its holdings in ASP Isotopes by 8.8% in the 1st quarter. The Manufacturers Life Insurance Company now owns 30,503 shares of the company’s stock worth $135,000 after acquiring an additional 2,470 shares during the period. Finally, BNP Paribas Financial Markets lifted its holdings in ASP Isotopes by 84.9% in the 2nd quarter. BNP Paribas Financial Markets now owns 5,549 shares of the company’s stock worth $41,000 after buying an additional 2,548 shares in the last quarter. 16.80% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling at ASP Isotopes

In related news, COO Robert Ainscow sold 25,000 shares of ASP Isotopes stock in a transaction on Wednesday, September 2nd. The stock was sold at an average price of $3.90, for a total value of $97,500.00. Following the transaction, the chief operating officer directly owned 2,256,879 shares in the company, valued at $8,801,828.10. The trade was a 1.10% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, CFO Heather Kiessling sold 23,124 shares of the business’s stock in a transaction on Wednesday, July 1st. The stock was sold at an average price of $6.28, for a total value of $145,218.72. Following the sale, the chief financial officer directly owned 1,526,252 shares in the company, valued at $9,584,862.56. This trade represents a 1.49% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Over the last quarter, insiders sold 304,079 shares of company stock worth $1,473,290. 14.40% of the stock is owned by insiders.

Analyst Upgrades and Downgrades

ASPI has been the subject of a number of research reports. Wall Street Zen upgraded ASP Isotopes from a “strong sell” rating to a “sell” rating in a research note on Saturday, August 22nd. Weiss Ratings reissued a “sell (d-)” rating on shares of ASP Isotopes in a report on Wednesday, June 24th. Two equities research analysts have rated the stock with a Buy rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus target price of $13.00.

ASP Isotopes Stock Up 7.7%

ASPI stock opened at $4.20 on Friday. The firm has a market cap of $643.90 million, a PE ratio of -3.18 and a beta of 3.59. ASP Isotopes Inc. has a 12 month low of $3.51 and a 12 month high of $14.49. The company has a debt-to-equity ratio of 0.76, a current ratio of 3.87 and a quick ratio of 3.85. The firm has a 50 day simple moving average of $4.37 and a 200 day simple moving average of $5.20.

ASP Isotopes (NASDAQ:ASPI) last posted its quarterly earnings results on Friday, August 14th. The company reported ($0.28) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.17) by ($0.11). The company had revenue of $5.12 million during the quarter, compared to the consensus estimate of $4.47 million. ASP Isotopes had a negative net margin of 427.98% and a negative return on equity of 64.99%.

ASP Isotopes Company Profile

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235. ASP Isotopes Inc was incorporated in 2021 and is headquartered in Washington, District Of Columbia.